← SynDRA
IB-MECA
SynDRA canonical compound SYN0004318 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | ADORA3 |
|---|
| Mechanism of action | Adenosine receptor agonist |
|---|
All known targets
- ADORA3
- ADORA1
- ADORA2A
- ADORA2B
Mechanisms of action (all sources)
- Adenosine receptor agonist
- ADORA1 AGONIST
- ADORA2A FULL AGONIST
- ADORA2B FULL AGONIST
- ADORA3 FULL AGONIST
- ADORA3 AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HTR2C
- HTR2B
- ADGRF1
- HTR5A
- HTR7
- MBD4
- MPG
- MUTYH
- NEIL1
- NEIL2
- NFE2L2
- NR1H2
- NR1H3
- NR3C1
- NTHL1
- PPARA
- PPARD
- PPARG
- PTH1R
- RXFP1
- S1PR1
- SLC5A7
- SMAD3
- TDG
- TDP1
- HTR6
- HTR3A
- HTR4
- ADRA2A
- ADRB2
- AGTR1
- APEX1
- APLNR
- ATAD5
- C5AR1
- CBX1
- CX3CR1
- EHMT2
- FFAR4
- FPR2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- AA1R
- AA2AR
- AA2BR
- ALR
- MRGPRX1
- SC5A7
- TMIG3
Cross-references
Synonyms
- piclidenoson
- CF 101
- 3-IB-Meca
- N(6)-Ibamu
- Cf101
- N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine
- UNII-30679UMI0N
- N(6)-(3-Iodobenzyl)adenosine-5'-N-methyluronamide
- 1-Deoxy-1-(6-(((3-iodophenyl)methyl)amino)-9H-purin-9-yl)-N-methyl-beta-D-ribofuranuronamide
- CHEMBL119709
- CHEBI:73286
- 30679UMI0N
- RPR-113090
- 3-iodobenzyl-5'-N-methylcarboxamidoadenosine
- N(6)-(3-iodo-benzyl)adenosine-5'-N-methyluronamide
- IB MECA
- ALB-7208
- SI-615
- piclidenosonum
- RefChem:863111
- Methyl 1-(N6-(3-iodobenzyl)-adenin-9-yl)-b-D-ribofuronamide
- N6-(3-Iodobenzyl)adenosine-5'-N-methyluronamide
- MFCD00671785
- Piclidenoson [USAN]
- IBMECA
- C18H19IN6O4
- HUJXGQILHAUCCV-MOROJQBDSA-N
- Q8L
- Piclidenoson (USAN/INN)
- PICLIDENOSON [INN]
- GTPL422
- MLS002153391
- PICLIDENOSON [WHO-DD]
- SCHEMBL465039
- orb1299997
- REGID_for_CID_123683
- SCHEMBL29384499
- SCHEMBL29572081
- GLXC-06152
Look up IB-MECA in the interactive SynDRA portal →